Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease

Plasma free fatty acid (FFA) concentration is elevated in obesity, insulin resistance (IR), non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and related comorbidities such as cardiovascular disease (CVD). Furthermore, experimentally manipulating plasma FFA in the laboratory setting...

Descripción completa

Detalles Bibliográficos
Autor principal: Henderson, Gregory C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402049/
https://www.ncbi.nlm.nih.gov/pubmed/34444750
http://dx.doi.org/10.3390/nu13082590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402049/
https://www.ncbi.nlm.nih.gov/pubmed/34444750
http://dx.doi.org/10.3390/nu13082590

Ejemplares similares